Novartis Ag (NVSEF) Gross Profit Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Gross Profit Growth (5y) (2014 - 2025) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Novartis Ag	-	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2025	7.04%
Jun 30, 2024	2.39%
Dec 31, 2023	79.67%
Jun 30, 2023	-1.31%
Mar 31, 2023	1,155.94%
Dec 31, 2022	86.08%
Sep 30, 2022	-73.93%
Jun 30, 2022	2.53%
Mar 31, 2022	-45.76%
Dec 31, 2021	-41.71%
Sep 30, 2021	-50.00%
Jun 30, 2021	66.96%
Mar 31, 2021	631.81%
Dec 31, 2020	128.46%
Sep 30, 2020	-97.17%
Jun 30, 2020	-82.21%
Mar 31, 2020	1,086.73%
Jun 30, 2019	2,840.52%
Mar 31, 2019	706.62%
Dec 31, 2018	641.46%